Erythrocyte and glomerular C4d deposits as a biomarker for active lupus nephritis
Authors:
Open Access
- 1 July 2018
- journal article
- research article
- Published by Elsevier in The Egyptian Rheumatologist
- Vol. 40 (3) , 167-171
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Anti-nucleosome antibodies in systemic lupus erythematosus patients: Relation to anti-double stranded deoxyribonucleic acid and disease activityThe Egyptian Rheumatologist, 2018
- Clinical significance of vitamin D deficiency and receptor gene polymorphism in systemic lupus erythematosus patientsThe Egyptian Rheumatologist, 2017
- IL22 in Egyptian SLE patients, could it reflect disease activity, skin or renal involvement or is it only an expensive ESR?The Egyptian Rheumatologist, 2017
- Clinical Association of a Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) in Patients with Systemic Lupus ErythematosusImmunological Investigations, 2016
- Potential serum and urine biomarkers in patients with lupus nephritis and the unsolved problemsOpen Access Rheumatology: Research and Reviews, 2016
- Expression of Toll‑like receptors 3 and 9 in Egyptian systemic lupus erythematosus patientsZeitschrift für Rheumatologie, 2015
- Lupus nephritis management guidelines comparedNephrology Dialysis Transplantation, 2015
- Measurement of Malondialdehyde, Glutathione, and Glutathione Peroxidase in SLE Patients2014
- Complement and autoimmunityImmunologic Research, 2013
- Systemic Lupus ErythematosusNew England Journal of Medicine, 2008